Abbott Vascular

Abbott's Voyager NC balloon dilation catheter
Abbott Vascular (Booth 2761) is introducing its Xience V everolimus-eluting coronary stent system and its Voyager NC balloon dilation catheter for the treatment of coronary artery disease (CAD). The Xience V, the latest DES to become FDA-approved, releases everolimus, which has been shown to help prevent restenosis.

The Voyager NC is Abbott's next-generation balloon dilatation catheter for the treatment of CAD. The device was designed to restore blood flow in both pre-dilatation and post-dilatation procedures, and is available in several balloon diameters (from 2 mm to 5 mm) and lengths (from 6 mm to 25 mm). The Voyager NC is available on a rapid exchange delivery system.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.